Diabetic Retinopathy and VEGF

被引:374
作者
Gupta, N. [1 ]
Mansoor, S. [1 ,2 ]
Sharma, A. [1 ,3 ]
Sapkal, A. [1 ]
Sheth, J. [3 ]
Falatoonzadeh, P. [1 ]
Kuppermann, B. D. [1 ]
Kenney, M. C. [1 ]
机构
[1] Univ Calif Irvine, Gavin Herbert Eye Inst, 843 Hlth Sci Rd,Hewitt Hall,Room 2028, Irvine, CA 92679 USA
[2] Georgia Inst Technol, Dept Chem & Biomol Engn, Atlanta, GA 30333 USA
[3] Lotus Eye Care Hosp, Dept Ophthalmol, Coimbatore, TN, India
关键词
Diabetic retinopathy; VEGF; DME; diabetes; central retinal vein occlusion; PGF;
D O I
10.2174/1874364101307010004
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Diabetic retinopathy remains the leading vascular-associated cause of blindness throughout the world. Its treatment requires a multidisciplinary interventional approach at both systemic and local levels. Current management includes laser photocoagulation, intravitreal steroids, and anti-vascular endothelial growth factor (VEGF) treatment along with systemic blood sugar control. Anti-VEGF therapies, which are less destructive and safer than laser treatments, are being explored as primary therapy for the management of vision-threatening complications of diabetic retinopathy such as diabetic macular edema (DME). This review provides comprehensive information related to VEGF and describes its role in the pathogenesis of diabetic retinopathy, and in addition, examines the mechanisms of action for different antiangiogenic agents in relation to the management of this disease. Medline (Pubmed) searches were carried out with keywords "VEGF", "diabetic retinopathy", and "diabetes" without any year limitation to review relevant manuscripts used for this article.
引用
收藏
页码:4 / 10
页数:7
相关论文
共 69 条
[1]   Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy [J].
Abraham, Prema ;
Adelman, Ron A. ;
Alfaro, Daniel Virgil, III ;
Anand, Rajiv ;
Antoszyk, Andrew ;
Bergsma, Donald ;
Hartnett, Mary Elizabeth ;
Brucker, Alexander J. ;
Carr, Tyree ;
Casey, Raynor C. ;
Rubino, John ;
Chandler, Thomas W. ;
Charles, Steven ;
Chaudhry, Nauman ;
Combs, James ;
Doft, Bernard ;
Young, Lucy H. Y. ;
Drouilhet, John H. ;
Dugel, Pravin U. ;
Feman, Stephen S. ;
Finkelstein, Daniel ;
Foster, Robert E. ;
Petersen, Michael R. ;
Fox, Gregory ;
Garretson, Bruce ;
Gieser, Jon P. ;
Gentile, Ronald C. ;
Giovinazzo, Vincent ;
Glazer, Louis ;
Goodart, Roy A. ;
Gottlieb, Justin ;
Greven, Craig ;
Grizzard, William S. ;
Hainsworth, Dean P. ;
Halperin, Lawrence ;
Heier, Jeffrey S. ;
Jackson, William ;
Kubacki, Joseph J. ;
Kanter, Eric D. ;
Keyser, Bruce ;
Kingsley, Ronald ;
Ko, Paula ;
Kokame, Gregg T. ;
Kuppermann, Baruch ;
Lambert, H. Michael ;
Lewis, Hilel ;
Lewis, Richard Alan ;
Marcus, Dennis ;
Nussbaum, Julian ;
Maturi, Raj K. .
OPHTHALMOLOGY, 2006, 113 (12) :2221-2230
[2]  
Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318
[3]   Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-Involved Diabetic Macular Edema [J].
Aiello, Lloyd Paul ;
Beck, Roy W. ;
Bressler, Neil M. ;
Browning, David J. ;
Chalam, K. V. ;
Davis, Matthew ;
Ferris, Frederick L., III ;
Glassman, Adam R. ;
Maturi, Raj K. ;
Stockdale, Cynthia R. ;
Topping, Trexler M. .
OPHTHALMOLOGY, 2011, 118 (12) :E5-E14
[4]  
Aiello LP, 2005, DIABETES, V54, P2188
[5]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[6]  
[Anonymous], 2008, DRUGS R&D, V9, P261
[7]   Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1 - A potential mechanism for vascular permeability in diabetic retinopathy and tumors [J].
Antonetti, DA ;
Barber, AJ ;
Hollinger, LA ;
Wolpert, EB ;
Gardner, TW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23463-23467
[8]   VITRECTOMY SURGERY FOR DIABETIC-RETINOPATHY [J].
BRESNICK, GH ;
MYERS, FL .
ANNUAL REVIEW OF MEDICINE, 1979, 30 :331-338
[9]   Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412 [J].
Campochiaro, PA .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (03) :922-931
[10]  
CASTILLEJOSRIOS D, 1992, CAN J OPHTHALMOL, V27, P243